Hajime Kubo
- Oncology top 0.5%
- Lymphatic System and Diseases 21
- Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer 17
- Ion channel regulation and function 15
- Bioactive natural compounds 11
-
- Cardiac electrophysiology and arrhythmias 20
- Physiology top 2%
- Surgery top 2%
- Tissue Engineering and Regenerative Medicine 13
-
- Botanical Research and Chemistry 24
-
- Chemical synthesis and alkaloids 19
- Co-authors
- Kari AlitaloSteven R. HouserTerhi KärpänenDavid G. JacksonMarc G. AchenSteven A. StackerShin‐Ichi NishikawaSeppo Ylä‐Herttuala
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Circulation (4 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- JapanUnited StatesFinland
In The Last Decade
Hajime Kubo
147 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 4.0k
- Molecular Biology 4.8k
- Cardiology and Cardiovascular Medicine 1.3k
- Physiology 1.2k
- Surgery 1.7k
Countries citing papers authored by Hajime Kubo
This map shows the geographic impact of Hajime Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajime Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajime Kubo more than expected).
Fields of papers citing papers by Hajime Kubo
This network shows the impact of papers produced by Hajime Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajime Kubo. The network helps show where Hajime Kubo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hajime Kubo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 12 | |
| 3 | 2014 | 97 | |
| 4 | 2014 | 14 | |
| 5 | 2014 | 3 | |
| 6 | 2013 | 14 | |
| 7 | 2012 | 72 | |
| 8 | 2010 | 1 | |
| 9 | 2009 | 116 | |
| 10 | 2009 | 20 | |
| 11 | Loss compensation using route diversity in wireless multicast | 2008 | 1 |
| 12 | 2008 | 56 | |
| 13 | 2007 | 17 | |
| 14 | 2007 | 125 | |
| 15 | 2006 | 78 | |
| 16 | 2005 | 109 | |
| 17 | 2003 | 209 | |
| 18 | Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.breakdown → | 2001 | 531 |
| 19 | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3breakdown → | 2001 | 612 |
| 20 | 1999 | 25 |
About Hajime Kubo
Hajime Kubo is a scholar working on Cardiology and Cardiovascular Medicine, Ecology, Evolution, Behavior and Systematics and Molecular Biology, having authored 149 papers that have together received 8.3k indexed citations. Recurring topics across this work include Botanical Research and Chemistry (24 papers), Lymphatic System and Diseases (21 papers), Cardiac electrophysiology and arrhythmias (20 papers), Chemical synthesis and alkaloids (19 papers), Angiogenesis and VEGF in Cancer (17 papers), Ion channel regulation and function (15 papers), Tissue Engineering and Regenerative Medicine (13 papers) and Bioactive natural compounds (11 papers). The work is most often cited by research in Oncology (4.0k citations), Molecular Biology (4.8k citations) and Cardiology and Cardiovascular Medicine (1.3k citations). Hajime Kubo has collaborated with scholars based in Japan, United States and Finland. Frequent co-authors include Kari Alitalo, Steven R. Houser, Terhi Kärpänen, David G. Jackson, Marc G. Achen, Steven A. Stacker, Shin‐Ichi Nishikawa, Seppo Ylä‐Herttuala, Remus M. Berretta and Taija Mäkinen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.